Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 1,487 | 0 | 1,113 | 1,138 | 1,948 |
| Cost of Goods | 488 | N/A | N/A | N/A | N/A |
| Gross Profit | 999 | N/A | 1,113 | 1,138 | 1,948 |
| Operating Expenses | 99,831 | 10,502 | 3,474 | 5,938 | 7,549 |
| Operating Income | -98,344 | -10,502 | -2,361 | -4,800 | -5,601 |
| Other Income | -3,531 | -1,592 | -334 | 1,093 | -4,242 |
| Pre-tax Income | -101,875 | -12,094 | -2,695 | -3,707 | -9,843 |
| Net Income Continuous | -101,875 | -12,094 | -2,695 | -3,707 | -9,843 |
| Minority Interests | -24 | N/A | -48 | -96 | -136 |
| Net Income | $-101,851 | $-12,094 | $-2,647 | $-3,612 | $-9,707 |
| EPS Basic Total Ops | -2.90 | -1.66 | -0.23 | -0.32 | -0.87 |
| EPS Basic Continuous Ops | -2.90 | -1.66 | -0.24 | -0.33 | -0.88 |
| EPS Diluted Total Ops | -2.90 | -1.66 | -0.23 | -0.32 | -0.87 |
| EPS Diluted Continuous Ops | -2.90 | -1.66 | -0.24 | -0.33 | -0.88 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -0.32 | -0.87 |
| EBITDA(a) | $-98,088 | $-10,501 | $-2,347 | $-4,782 | $-5,580 |